nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2B6—Sorafenib—thyroid cancer	0.0659	0.446	CbGbCtD
Memantine—CYP2C19—Sorafenib—thyroid cancer	0.0419	0.283	CbGbCtD
Memantine—CYP2B6—Doxorubicin—thyroid cancer	0.04	0.271	CbGbCtD
Memantine—CYP2B6—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00183	0.0273	CbGpPWpGaD
Memantine—GRIN1—Mecp2 and Associated Rett Syndrome—SST—thyroid cancer	0.00167	0.025	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—RET—thyroid cancer	0.0016	0.0239	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00149	0.0223	CbGpPWpGaD
Memantine—GRIN2B—ErbB4 signaling events—NRG1—thyroid cancer	0.00147	0.0219	CbGpPWpGaD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—BRAF—thyroid cancer	0.00143	0.0213	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00133	0.0199	CbGpPWpGaD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—BRAF—thyroid cancer	0.00124	0.0186	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00124	0.0185	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—BRAF—thyroid cancer	0.00121	0.0181	CbGpPWpGaD
Memantine—GRIN2A—Post NMDA receptor activation events—BRAF—thyroid cancer	0.00117	0.0175	CbGpPWpGaD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—thyroid cancer	0.00108	0.0162	CbGpPWpGaD
Memantine—CYP2C19—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00105	0.0158	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—LGALS3—thyroid cancer	0.00104	0.0155	CbGpPWpGaD
Memantine—GRIN1—Post NMDA receptor activation events—BRAF—thyroid cancer	0.00102	0.0153	CbGpPWpGaD
Memantine—GRIN2B—Post NMDA receptor activation events—BRAF—thyroid cancer	0.000998	0.0149	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00099	0.0148	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.000969	0.0145	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—thyroid cancer	0.000943	0.0141	CbGpPWpGaD
Memantine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—thyroid cancer	0.000919	0.0137	CbGpPWpGaD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—thyroid cancer	0.000919	0.0137	CbGpPWpGaD
Memantine—CYP2A6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000892	0.0133	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.000823	0.0123	CbGpPWpGaD
Memantine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—thyroid cancer	0.000802	0.012	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000782	0.0117	CbGpPWpGaD
Memantine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—thyroid cancer	0.000782	0.0117	CbGpPWpGaD
Memantine—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—thyroid cancer	0.000772	0.0115	CbGpPWpGaD
Memantine—CYP2B6—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00072	0.0108	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CDK1—thyroid cancer	0.000709	0.0106	CbGpPWpGaD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—thyroid cancer	0.000656	0.0098	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000651	0.00973	CbGpPWpGaD
Memantine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000636	0.00951	CbGpPWpGaD
Memantine—CYP2B6—Metapathway biotransformation—CHST14—thyroid cancer	0.000635	0.00949	CbGpPWpGaD
Memantine—GRIN2A—Reelin signaling pathway—AKT1—thyroid cancer	0.000595	0.0089	CbGpPWpGaD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—thyroid cancer	0.000572	0.00855	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—thyroid cancer	0.000557	0.00833	CbGpPWpGaD
Memantine—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000544	0.00813	CbGpPWpGaD
Memantine—CYP2A6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00054	0.00807	CbGpPWpGaD
Memantine—GRIN2A—Post NMDA receptor activation events—HRAS—thyroid cancer	0.000539	0.00807	CbGpPWpGaD
Memantine—GRIN2B—Reelin signaling pathway—AKT1—thyroid cancer	0.000506	0.00757	CbGpPWpGaD
Memantine—Nasopharyngitis—Epirubicin—thyroid cancer	0.0005	0.000637	CcSEcCtD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—thyroid cancer	0.000497	0.00743	CbGpPWpGaD
Memantine—Gastritis—Epirubicin—thyroid cancer	0.000495	0.00063	CcSEcCtD
Memantine—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000493	0.000628	CcSEcCtD
Memantine—Muscular weakness—Epirubicin—thyroid cancer	0.000493	0.000628	CcSEcCtD
Memantine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000492	0.000626	CcSEcCtD
Memantine—Dizziness—Sorafenib—thyroid cancer	0.000492	0.000626	CcSEcCtD
Memantine—Mood swings—Doxorubicin—thyroid cancer	0.00049	0.000624	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—NKX2-1—thyroid cancer	0.000487	0.00728	CbGpPWpGaD
Memantine—Ataxia—Doxorubicin—thyroid cancer	0.000486	0.000619	CcSEcCtD
Memantine—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000485	0.000617	CcSEcCtD
Memantine—Asthma—Epirubicin—thyroid cancer	0.000483	0.000615	CcSEcCtD
Memantine—Influenza—Epirubicin—thyroid cancer	0.000483	0.000615	CcSEcCtD
Memantine—Dysphagia—Epirubicin—thyroid cancer	0.000483	0.000615	CcSEcCtD
Memantine—Dehydration—Doxorubicin—thyroid cancer	0.000481	0.000613	CcSEcCtD
Memantine—CYP2C19—Metapathway biotransformation—CHST14—thyroid cancer	0.00048	0.00717	CbGpPWpGaD
Memantine—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000478	0.000608	CcSEcCtD
Memantine—Dry skin—Doxorubicin—thyroid cancer	0.000474	0.000604	CcSEcCtD
Memantine—Pancreatitis—Epirubicin—thyroid cancer	0.000474	0.000603	CcSEcCtD
Memantine—Vomiting—Sorafenib—thyroid cancer	0.000473	0.000602	CcSEcCtD
Memantine—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000472	0.000602	CcSEcCtD
Memantine—Hypokalaemia—Doxorubicin—thyroid cancer	0.000471	0.000599	CcSEcCtD
Memantine—Angina pectoris—Epirubicin—thyroid cancer	0.000471	0.000599	CcSEcCtD
Memantine—GRIN1—Post NMDA receptor activation events—HRAS—thyroid cancer	0.000471	0.00704	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00047	0.00702	CbGpPWpGaD
Memantine—Rash—Sorafenib—thyroid cancer	0.000469	0.000597	CcSEcCtD
Memantine—Dermatitis—Sorafenib—thyroid cancer	0.000468	0.000596	CcSEcCtD
Memantine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000466	0.000593	CcSEcCtD
Memantine—Headache—Sorafenib—thyroid cancer	0.000466	0.000593	CcSEcCtD
Memantine—Bronchitis—Epirubicin—thyroid cancer	0.000465	0.000592	CcSEcCtD
Memantine—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000463	0.000589	CcSEcCtD
Memantine—Pancytopenia—Epirubicin—thyroid cancer	0.000459	0.000584	CcSEcCtD
Memantine—GRIN2B—Post NMDA receptor activation events—HRAS—thyroid cancer	0.000459	0.00686	CbGpPWpGaD
Memantine—Gastritis—Doxorubicin—thyroid cancer	0.000458	0.000583	CcSEcCtD
Memantine—Muscular weakness—Doxorubicin—thyroid cancer	0.000456	0.000581	CcSEcCtD
Memantine—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000456	0.000581	CcSEcCtD
Memantine—Dysuria—Epirubicin—thyroid cancer	0.000452	0.000575	CcSEcCtD
Memantine—Neutropenia—Epirubicin—thyroid cancer	0.000452	0.000575	CcSEcCtD
Memantine—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000449	0.000572	CcSEcCtD
Memantine—Asthma—Doxorubicin—thyroid cancer	0.000447	0.000569	CcSEcCtD
Memantine—Influenza—Doxorubicin—thyroid cancer	0.000447	0.000569	CcSEcCtD
Memantine—Dysphagia—Doxorubicin—thyroid cancer	0.000447	0.000569	CcSEcCtD
Memantine—Pollakiuria—Epirubicin—thyroid cancer	0.000446	0.000568	CcSEcCtD
Memantine—Nausea—Sorafenib—thyroid cancer	0.000442	0.000562	CcSEcCtD
Memantine—Weight increased—Epirubicin—thyroid cancer	0.00044	0.00056	CcSEcCtD
Memantine—Pancreatitis—Doxorubicin—thyroid cancer	0.000438	0.000558	CcSEcCtD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000437	0.00654	CbGpPWpGaD
Memantine—Weight decreased—Epirubicin—thyroid cancer	0.000437	0.000557	CcSEcCtD
Memantine—Hyperglycaemia—Epirubicin—thyroid cancer	0.000436	0.000555	CcSEcCtD
Memantine—Angina pectoris—Doxorubicin—thyroid cancer	0.000436	0.000555	CcSEcCtD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000435	0.00651	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—thyroid cancer	0.000433	0.00648	CbGpPWpGaD
Memantine—GRIN1—EPHB-mediated forward signaling—HRAS—thyroid cancer	0.000433	0.00648	CbGpPWpGaD
Memantine—Pneumonia—Epirubicin—thyroid cancer	0.000433	0.000552	CcSEcCtD
Memantine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000433	0.00647	CbGpPWpGaD
Memantine—Infestation—Epirubicin—thyroid cancer	0.000431	0.000549	CcSEcCtD
Memantine—Infestation NOS—Epirubicin—thyroid cancer	0.000431	0.000549	CcSEcCtD
Memantine—Bronchitis—Doxorubicin—thyroid cancer	0.00043	0.000548	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000427	0.000544	CcSEcCtD
Memantine—Pancytopenia—Doxorubicin—thyroid cancer	0.000425	0.000541	CcSEcCtD
Memantine—Renal failure—Epirubicin—thyroid cancer	0.000424	0.000539	CcSEcCtD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—thyroid cancer	0.000423	0.00632	CbGpPWpGaD
Memantine—GRIN2B—EPHB-mediated forward signaling—HRAS—thyroid cancer	0.000423	0.00632	CbGpPWpGaD
Memantine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000422	0.000538	CcSEcCtD
Memantine—Urinary tract infection—Epirubicin—thyroid cancer	0.000419	0.000533	CcSEcCtD
Memantine—Conjunctivitis—Epirubicin—thyroid cancer	0.000419	0.000533	CcSEcCtD
Memantine—Dysuria—Doxorubicin—thyroid cancer	0.000418	0.000532	CcSEcCtD
Memantine—Neutropenia—Doxorubicin—thyroid cancer	0.000418	0.000532	CcSEcCtD
Memantine—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000416	0.000529	CcSEcCtD
Memantine—Pollakiuria—Doxorubicin—thyroid cancer	0.000413	0.000526	CcSEcCtD
Memantine—Haematuria—Epirubicin—thyroid cancer	0.000411	0.000523	CcSEcCtD
Memantine—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000407	0.000519	CcSEcCtD
Memantine—Weight increased—Doxorubicin—thyroid cancer	0.000407	0.000518	CcSEcCtD
Memantine—Epistaxis—Epirubicin—thyroid cancer	0.000406	0.000517	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000405	0.00605	CbGpPWpGaD
Memantine—Weight decreased—Doxorubicin—thyroid cancer	0.000405	0.000515	CcSEcCtD
Memantine—Sinusitis—Epirubicin—thyroid cancer	0.000404	0.000515	CcSEcCtD
Memantine—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000403	0.000514	CcSEcCtD
Memantine—Agranulocytosis—Epirubicin—thyroid cancer	0.000402	0.000512	CcSEcCtD
Memantine—Pneumonia—Doxorubicin—thyroid cancer	0.000401	0.000511	CcSEcCtD
Memantine—Infestation NOS—Doxorubicin—thyroid cancer	0.000399	0.000508	CcSEcCtD
Memantine—Infestation—Doxorubicin—thyroid cancer	0.000399	0.000508	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000395	0.000503	CcSEcCtD
Memantine—Bradycardia—Epirubicin—thyroid cancer	0.000394	0.000501	CcSEcCtD
Memantine—Renal failure—Doxorubicin—thyroid cancer	0.000392	0.000499	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000391	0.00584	CbGpPWpGaD
Memantine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000391	0.000498	CcSEcCtD
Memantine—Haemoglobin—Epirubicin—thyroid cancer	0.000389	0.000495	CcSEcCtD
Memantine—Rhinitis—Epirubicin—thyroid cancer	0.000388	0.000494	CcSEcCtD
Memantine—Urinary tract infection—Doxorubicin—thyroid cancer	0.000388	0.000493	CcSEcCtD
Memantine—Conjunctivitis—Doxorubicin—thyroid cancer	0.000388	0.000493	CcSEcCtD
Memantine—Hepatitis—Epirubicin—thyroid cancer	0.000387	0.000493	CcSEcCtD
Memantine—Haemorrhage—Epirubicin—thyroid cancer	0.000387	0.000493	CcSEcCtD
Memantine—Hypoaesthesia—Epirubicin—thyroid cancer	0.000385	0.00049	CcSEcCtD
Memantine—Pharyngitis—Epirubicin—thyroid cancer	0.000384	0.000489	CcSEcCtD
Memantine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000382	0.000486	CcSEcCtD
Memantine—Oedema peripheral—Epirubicin—thyroid cancer	0.000381	0.000485	CcSEcCtD
Memantine—Haematuria—Doxorubicin—thyroid cancer	0.00038	0.000484	CcSEcCtD
Memantine—Connective tissue disorder—Epirubicin—thyroid cancer	0.00038	0.000484	CcSEcCtD
Memantine—Urethral disorder—Epirubicin—thyroid cancer	0.000379	0.000483	CcSEcCtD
Memantine—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000377	0.00048	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—thyroid cancer	0.000376	0.000479	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—thyroid cancer	0.000374	0.000476	CcSEcCtD
Memantine—Visual impairment—Epirubicin—thyroid cancer	0.000373	0.000475	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—thyroid cancer	0.000372	0.000474	CcSEcCtD
Memantine—Erythema multiforme—Epirubicin—thyroid cancer	0.000366	0.000466	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—thyroid cancer	0.000364	0.000464	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—CALCB—thyroid cancer	0.000362	0.00541	CbGpPWpGaD
Memantine—Eye disorder—Epirubicin—thyroid cancer	0.000361	0.00046	CcSEcCtD
Memantine—Tinnitus—Epirubicin—thyroid cancer	0.000361	0.000459	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—thyroid cancer	0.00036	0.000458	CcSEcCtD
Memantine—Flushing—Epirubicin—thyroid cancer	0.000359	0.000457	CcSEcCtD
Memantine—Cardiac disorder—Epirubicin—thyroid cancer	0.000359	0.000457	CcSEcCtD
Memantine—Rhinitis—Doxorubicin—thyroid cancer	0.000359	0.000457	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—thyroid cancer	0.000358	0.000456	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—thyroid cancer	0.000358	0.000456	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000356	0.000453	CcSEcCtD
Memantine—Pharyngitis—Doxorubicin—thyroid cancer	0.000355	0.000452	CcSEcCtD
Memantine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000353	0.00045	CcSEcCtD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000353	0.00528	CbGpPWpGaD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000353	0.00528	CbGpPWpGaD
Memantine—Oedema peripheral—Doxorubicin—thyroid cancer	0.000353	0.000449	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000352	0.000448	CcSEcCtD
Memantine—Angiopathy—Epirubicin—thyroid cancer	0.000351	0.000447	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—thyroid cancer	0.000351	0.000447	CcSEcCtD
Memantine—Immune system disorder—Epirubicin—thyroid cancer	0.000349	0.000445	CcSEcCtD
Memantine—Mediastinal disorder—Epirubicin—thyroid cancer	0.000349	0.000444	CcSEcCtD
Memantine—Chills—Epirubicin—thyroid cancer	0.000347	0.000442	CcSEcCtD
Memantine—Arrhythmia—Epirubicin—thyroid cancer	0.000346	0.00044	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—thyroid cancer	0.000345	0.000439	CcSEcCtD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—thyroid cancer	0.000344	0.00514	CbGpPWpGaD
Memantine—Alopecia—Epirubicin—thyroid cancer	0.000342	0.000435	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00034	0.00508	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—CP—thyroid cancer	0.00034	0.00508	CbGpPWpGaD
Memantine—Mental disorder—Epirubicin—thyroid cancer	0.000339	0.000431	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—thyroid cancer	0.000338	0.000431	CcSEcCtD
Memantine—Malnutrition—Epirubicin—thyroid cancer	0.000337	0.000429	CcSEcCtD
Memantine—Eye disorder—Doxorubicin—thyroid cancer	0.000334	0.000426	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000334	0.005	CbGpPWpGaD
Memantine—Tinnitus—Doxorubicin—thyroid cancer	0.000334	0.000425	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—thyroid cancer	0.000332	0.000423	CcSEcCtD
Memantine—Flushing—Doxorubicin—thyroid cancer	0.000332	0.000423	CcSEcCtD
Memantine—Flatulence—Epirubicin—thyroid cancer	0.000332	0.000422	CcSEcCtD
Memantine—Tension—Epirubicin—thyroid cancer	0.00033	0.000421	CcSEcCtD
Memantine—Dysgeusia—Epirubicin—thyroid cancer	0.00033	0.00042	CcSEcCtD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000329	0.00492	CbGpPWpGaD
Memantine—Nervousness—Epirubicin—thyroid cancer	0.000327	0.000416	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—PTGS2—thyroid cancer	0.000327	0.00489	CbGpPWpGaD
Memantine—Back pain—Epirubicin—thyroid cancer	0.000326	0.000415	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—thyroid cancer	0.000325	0.000413	CcSEcCtD
Memantine—Immune system disorder—Doxorubicin—thyroid cancer	0.000323	0.000412	CcSEcCtD
Memantine—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000323	0.000411	CcSEcCtD
Memantine—Chills—Doxorubicin—thyroid cancer	0.000321	0.000409	CcSEcCtD
Memantine—Arrhythmia—Doxorubicin—thyroid cancer	0.00032	0.000407	CcSEcCtD
Memantine—Vision blurred—Epirubicin—thyroid cancer	0.000317	0.000404	CcSEcCtD
Memantine—Alopecia—Doxorubicin—thyroid cancer	0.000316	0.000403	CcSEcCtD
Memantine—GRIN1—Axon guidance—CDK1—thyroid cancer	0.000316	0.00473	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—SLC5A5—thyroid cancer	0.000315	0.00471	CbGpPWpGaD
Memantine—Mental disorder—Doxorubicin—thyroid cancer	0.000314	0.000399	CcSEcCtD
Memantine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000312	0.000398	CcSEcCtD
Memantine—Malnutrition—Doxorubicin—thyroid cancer	0.000312	0.000397	CcSEcCtD
Memantine—Anaemia—Epirubicin—thyroid cancer	0.000311	0.000396	CcSEcCtD
Memantine—Agitation—Epirubicin—thyroid cancer	0.000309	0.000394	CcSEcCtD
Memantine—GRIN2B—Axon guidance—CDK1—thyroid cancer	0.000308	0.00461	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—thyroid cancer	0.000307	0.0046	CbGpPWpGaD
Memantine—Flatulence—Doxorubicin—thyroid cancer	0.000307	0.000391	CcSEcCtD
Memantine—Tension—Doxorubicin—thyroid cancer	0.000306	0.000389	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—thyroid cancer	0.000305	0.000388	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000304	0.00455	CbGpPWpGaD
Memantine—Malaise—Epirubicin—thyroid cancer	0.000304	0.000387	CcSEcCtD
Memantine—Nervousness—Doxorubicin—thyroid cancer	0.000303	0.000385	CcSEcCtD
Memantine—Vertigo—Epirubicin—thyroid cancer	0.000303	0.000385	CcSEcCtD
Memantine—Syncope—Epirubicin—thyroid cancer	0.000302	0.000384	CcSEcCtD
Memantine—Leukopenia—Epirubicin—thyroid cancer	0.000301	0.000384	CcSEcCtD
Memantine—Back pain—Doxorubicin—thyroid cancer	0.000301	0.000384	CcSEcCtD
Memantine—Palpitations—Epirubicin—thyroid cancer	0.000298	0.000379	CcSEcCtD
Memantine—Loss of consciousness—Epirubicin—thyroid cancer	0.000296	0.000377	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—CCND1—thyroid cancer	0.000295	0.00442	CbGpPWpGaD
Memantine—Cough—Epirubicin—thyroid cancer	0.000294	0.000374	CcSEcCtD
Memantine—Vision blurred—Doxorubicin—thyroid cancer	0.000294	0.000374	CcSEcCtD
Memantine—Convulsion—Epirubicin—thyroid cancer	0.000292	0.000371	CcSEcCtD
Memantine—Hypertension—Epirubicin—thyroid cancer	0.000291	0.00037	CcSEcCtD
Memantine—SLC22A2—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000289	0.00432	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000289	0.00432	CbGpPWpGaD
Memantine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000289	0.000368	CcSEcCtD
Memantine—Anaemia—Doxorubicin—thyroid cancer	0.000288	0.000367	CcSEcCtD
Memantine—Myalgia—Epirubicin—thyroid cancer	0.000287	0.000365	CcSEcCtD
Memantine—Chest pain—Epirubicin—thyroid cancer	0.000287	0.000365	CcSEcCtD
Memantine—Arthralgia—Epirubicin—thyroid cancer	0.000287	0.000365	CcSEcCtD
Memantine—Agitation—Doxorubicin—thyroid cancer	0.000286	0.000365	CcSEcCtD
Memantine—Anxiety—Epirubicin—thyroid cancer	0.000286	0.000364	CcSEcCtD
Memantine—Discomfort—Epirubicin—thyroid cancer	0.000283	0.000361	CcSEcCtD
Memantine—Malaise—Doxorubicin—thyroid cancer	0.000281	0.000358	CcSEcCtD
Memantine—Dry mouth—Epirubicin—thyroid cancer	0.00028	0.000357	CcSEcCtD
Memantine—Vertigo—Doxorubicin—thyroid cancer	0.00028	0.000356	CcSEcCtD
Memantine—Syncope—Doxorubicin—thyroid cancer	0.000279	0.000356	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—thyroid cancer	0.000279	0.000355	CcSEcCtD
Memantine—Confusional state—Epirubicin—thyroid cancer	0.000277	0.000353	CcSEcCtD
Memantine—Palpitations—Doxorubicin—thyroid cancer	0.000275	0.000351	CcSEcCtD
Memantine—Oedema—Epirubicin—thyroid cancer	0.000275	0.00035	CcSEcCtD
Memantine—Loss of consciousness—Doxorubicin—thyroid cancer	0.000274	0.000349	CcSEcCtD
Memantine—Infection—Epirubicin—thyroid cancer	0.000273	0.000348	CcSEcCtD
Memantine—Cough—Doxorubicin—thyroid cancer	0.000272	0.000346	CcSEcCtD
Memantine—Shock—Epirubicin—thyroid cancer	0.00027	0.000344	CcSEcCtD
Memantine—Convulsion—Doxorubicin—thyroid cancer	0.00027	0.000344	CcSEcCtD
Memantine—Nervous system disorder—Epirubicin—thyroid cancer	0.000269	0.000343	CcSEcCtD
Memantine—Thrombocytopenia—Epirubicin—thyroid cancer	0.000269	0.000343	CcSEcCtD
Memantine—Hypertension—Doxorubicin—thyroid cancer	0.000269	0.000342	CcSEcCtD
Memantine—GRIN1—Alzheimers Disease—TP53—thyroid cancer	0.000268	0.00401	CbGpPWpGaD
Memantine—Tachycardia—Epirubicin—thyroid cancer	0.000268	0.000342	CcSEcCtD
Memantine—Skin disorder—Epirubicin—thyroid cancer	0.000267	0.00034	CcSEcCtD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000267	0.00399	CbGpPWpGaD
Memantine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000266	0.000338	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000265	0.00397	CbGpPWpGaD
Memantine—Arthralgia—Doxorubicin—thyroid cancer	0.000265	0.000338	CcSEcCtD
Memantine—Chest pain—Doxorubicin—thyroid cancer	0.000265	0.000338	CcSEcCtD
Memantine—Myalgia—Doxorubicin—thyroid cancer	0.000265	0.000338	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—RXRA—thyroid cancer	0.000265	0.00396	CbGpPWpGaD
Memantine—Anxiety—Doxorubicin—thyroid cancer	0.000264	0.000337	CcSEcCtD
Memantine—Discomfort—Doxorubicin—thyroid cancer	0.000262	0.000334	CcSEcCtD
Memantine—Anorexia—Epirubicin—thyroid cancer	0.000262	0.000334	CcSEcCtD
Memantine—GRIN2B—Alzheimers Disease—TP53—thyroid cancer	0.000261	0.00391	CbGpPWpGaD
Memantine—Dry mouth—Doxorubicin—thyroid cancer	0.000259	0.00033	CcSEcCtD
Memantine—GRIN2B—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000259	0.00387	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000257	0.00385	CbGpPWpGaD
Memantine—Hypotension—Epirubicin—thyroid cancer	0.000257	0.000327	CcSEcCtD
Memantine—Confusional state—Doxorubicin—thyroid cancer	0.000256	0.000326	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000254	0.0038	CbGpPWpGaD
Memantine—Oedema—Doxorubicin—thyroid cancer	0.000254	0.000324	CcSEcCtD
Memantine—Infection—Doxorubicin—thyroid cancer	0.000253	0.000322	CcSEcCtD
Memantine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00025	0.000319	CcSEcCtD
Memantine—Shock—Doxorubicin—thyroid cancer	0.00025	0.000319	CcSEcCtD
Memantine—Nervous system disorder—Doxorubicin—thyroid cancer	0.000249	0.000318	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000249	0.000317	CcSEcCtD
Memantine—Insomnia—Epirubicin—thyroid cancer	0.000249	0.000316	CcSEcCtD
Memantine—Tachycardia—Doxorubicin—thyroid cancer	0.000248	0.000316	CcSEcCtD
Memantine—Skin disorder—Doxorubicin—thyroid cancer	0.000247	0.000314	CcSEcCtD
Memantine—Paraesthesia—Epirubicin—thyroid cancer	0.000247	0.000314	CcSEcCtD
Memantine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000246	0.000313	CcSEcCtD
Memantine—Dyspnoea—Epirubicin—thyroid cancer	0.000245	0.000312	CcSEcCtD
Memantine—Somnolence—Epirubicin—thyroid cancer	0.000244	0.000311	CcSEcCtD
Memantine—Anorexia—Doxorubicin—thyroid cancer	0.000242	0.000309	CcSEcCtD
Memantine—Dyspepsia—Epirubicin—thyroid cancer	0.000242	0.000308	CcSEcCtD
Memantine—Decreased appetite—Epirubicin—thyroid cancer	0.000239	0.000304	CcSEcCtD
Memantine—Hypotension—Doxorubicin—thyroid cancer	0.000238	0.000303	CcSEcCtD
Memantine—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000237	0.000302	CcSEcCtD
Memantine—Fatigue—Epirubicin—thyroid cancer	0.000237	0.000302	CcSEcCtD
Memantine—Pain—Epirubicin—thyroid cancer	0.000235	0.000299	CcSEcCtD
Memantine—Constipation—Epirubicin—thyroid cancer	0.000235	0.000299	CcSEcCtD
Memantine—GRIN2A—Neuronal System—BRAF—thyroid cancer	0.000233	0.00349	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—RXRA—thyroid cancer	0.000232	0.00347	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000232	0.000295	CcSEcCtD
Memantine—Insomnia—Doxorubicin—thyroid cancer	0.00023	0.000293	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—NRG1—thyroid cancer	0.000229	0.00343	CbGpPWpGaD
Memantine—Paraesthesia—Doxorubicin—thyroid cancer	0.000228	0.000291	CcSEcCtD
Memantine—Dyspnoea—Doxorubicin—thyroid cancer	0.000227	0.000289	CcSEcCtD
Memantine—Feeling abnormal—Epirubicin—thyroid cancer	0.000226	0.000288	CcSEcCtD
Memantine—Somnolence—Doxorubicin—thyroid cancer	0.000226	0.000288	CcSEcCtD
Memantine—GRIN1—Developmental Biology—CDK1—thyroid cancer	0.000226	0.00337	CbGpPWpGaD
Memantine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000225	0.000286	CcSEcCtD
Memantine—Dyspepsia—Doxorubicin—thyroid cancer	0.000224	0.000285	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—HRAS—thyroid cancer	0.000223	0.00334	CbGpPWpGaD
Memantine—Decreased appetite—Doxorubicin—thyroid cancer	0.000221	0.000281	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—thyroid cancer	0.00022	0.00329	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CDK1—thyroid cancer	0.00022	0.00329	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00022	0.00028	CcSEcCtD
Memantine—Fatigue—Doxorubicin—thyroid cancer	0.000219	0.000279	CcSEcCtD
Memantine—Urticaria—Epirubicin—thyroid cancer	0.000218	0.000278	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—HRAS—thyroid cancer	0.000218	0.00325	CbGpPWpGaD
Memantine—Constipation—Doxorubicin—thyroid cancer	0.000217	0.000277	CcSEcCtD
Memantine—Pain—Doxorubicin—thyroid cancer	0.000217	0.000277	CcSEcCtD
Memantine—Abdominal pain—Epirubicin—thyroid cancer	0.000217	0.000277	CcSEcCtD
Memantine—Body temperature increased—Epirubicin—thyroid cancer	0.000217	0.000277	CcSEcCtD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000216	0.00324	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—SST—thyroid cancer	0.000215	0.00322	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000214	0.00319	CbGpPWpGaD
Memantine—Feeling abnormal—Doxorubicin—thyroid cancer	0.00021	0.000267	CcSEcCtD
Memantine—GRIN1—Developmental Biology—RXRA—thyroid cancer	0.000209	0.00313	CbGpPWpGaD
Memantine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000208	0.000265	CcSEcCtD
Memantine—DRD2—GPCR downstream signaling—CALCB—thyroid cancer	0.000204	0.00306	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—RXRA—thyroid cancer	0.000204	0.00305	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—BRAF—thyroid cancer	0.000203	0.00304	CbGpPWpGaD
Memantine—Hypersensitivity—Epirubicin—thyroid cancer	0.000202	0.000258	CcSEcCtD
Memantine—Urticaria—Doxorubicin—thyroid cancer	0.000202	0.000257	CcSEcCtD
Memantine—Body temperature increased—Doxorubicin—thyroid cancer	0.000201	0.000256	CcSEcCtD
Memantine—Abdominal pain—Doxorubicin—thyroid cancer	0.000201	0.000256	CcSEcCtD
Memantine—GRIN2B—Neuronal System—BRAF—thyroid cancer	0.000198	0.00296	CbGpPWpGaD
Memantine—Asthenia—Epirubicin—thyroid cancer	0.000197	0.000251	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—TP53—thyroid cancer	0.000195	0.00291	CbGpPWpGaD
Memantine—Pruritus—Epirubicin—thyroid cancer	0.000194	0.000248	CcSEcCtD
Memantine—CYP2C19—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000189	0.00283	CbGpPWpGaD
Memantine—Diarrhoea—Epirubicin—thyroid cancer	0.000188	0.000239	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—RXRA—thyroid cancer	0.000187	0.0028	CbGpPWpGaD
Memantine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000187	0.000239	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000186	0.00278	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MINPP1—thyroid cancer	0.000186	0.00278	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CALCB—thyroid cancer	0.000186	0.00278	CbGpPWpGaD
Memantine—Asthenia—Doxorubicin—thyroid cancer	0.000182	0.000232	CcSEcCtD
Memantine—Dizziness—Epirubicin—thyroid cancer	0.000182	0.000231	CcSEcCtD
Memantine—Pruritus—Doxorubicin—thyroid cancer	0.00018	0.000229	CcSEcCtD
Memantine—Vomiting—Epirubicin—thyroid cancer	0.000175	0.000222	CcSEcCtD
Memantine—Diarrhoea—Doxorubicin—thyroid cancer	0.000174	0.000222	CcSEcCtD
Memantine—Rash—Epirubicin—thyroid cancer	0.000173	0.000221	CcSEcCtD
Memantine—Dermatitis—Epirubicin—thyroid cancer	0.000173	0.00022	CcSEcCtD
Memantine—Headache—Epirubicin—thyroid cancer	0.000172	0.000219	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—thyroid cancer	0.000171	0.00256	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MINPP1—thyroid cancer	0.000171	0.00255	CbGpPWpGaD
Memantine—Dizziness—Doxorubicin—thyroid cancer	0.000168	0.000214	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—TSHR—thyroid cancer	0.000168	0.0025	CbGpPWpGaD
Memantine—Nausea—Epirubicin—thyroid cancer	0.000163	0.000208	CcSEcCtD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000162	0.00243	CbGpPWpGaD
Memantine—Vomiting—Doxorubicin—thyroid cancer	0.000162	0.000206	CcSEcCtD
Memantine—Rash—Doxorubicin—thyroid cancer	0.00016	0.000204	CcSEcCtD
Memantine—Dermatitis—Doxorubicin—thyroid cancer	0.00016	0.000204	CcSEcCtD
Memantine—Headache—Doxorubicin—thyroid cancer	0.000159	0.000203	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—HRAS—thyroid cancer	0.000159	0.00237	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—thyroid cancer	0.000158	0.00237	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NDUFA13—thyroid cancer	0.000158	0.00236	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—HRAS—thyroid cancer	0.000155	0.00231	CbGpPWpGaD
Memantine—Nausea—Doxorubicin—thyroid cancer	0.000151	0.000192	CcSEcCtD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000151	0.00225	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CHST14—thyroid cancer	0.000149	0.00222	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000147	0.0022	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000147	0.0022	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NDUFA13—thyroid cancer	0.000145	0.00217	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000145	0.00216	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—PTCH1—thyroid cancer	0.000142	0.00213	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—RXRA—thyroid cancer	0.000142	0.00212	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—AKT1—thyroid cancer	0.00014	0.00209	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.00014	0.00209	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000138	0.00206	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MINPP1—thyroid cancer	0.000138	0.00206	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—AKT1—thyroid cancer	0.000137	0.00204	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CHST14—thyroid cancer	0.000136	0.00204	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—PPARG—thyroid cancer	0.000132	0.00198	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—SST—thyroid cancer	0.00013	0.00195	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—PPARG—thyroid cancer	0.000129	0.00193	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CALCA—thyroid cancer	0.000125	0.00188	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—PPARG—thyroid cancer	0.000125	0.00186	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000122	0.00182	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HPGD—thyroid cancer	0.00012	0.00179	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000119	0.00178	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NDUFA13—thyroid cancer	0.000117	0.00175	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—NRAS—thyroid cancer	0.000113	0.0017	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—NRAS—thyroid cancer	0.000111	0.00165	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CHST14—thyroid cancer	0.00011	0.00165	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HPGD—thyroid cancer	0.00011	0.00164	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00011	0.00164	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CALCB—thyroid cancer	0.00011	0.00164	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—HRAS—thyroid cancer	0.000107	0.0016	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—BRAF—thyroid cancer	0.000106	0.00158	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MINPP1—thyroid cancer	0.000104	0.00156	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TRIM33—thyroid cancer	0.000104	0.00155	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—KRAS—thyroid cancer	9.76e-05	0.00146	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—KRAS—thyroid cancer	9.51e-05	0.00142	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—TSHR—thyroid cancer	9.47e-05	0.00142	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—HRAS—thyroid cancer	9.35e-05	0.0014	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.24e-05	0.00138	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—HRAS—thyroid cancer	9.11e-05	0.00136	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HPGD—thyroid cancer	8.87e-05	0.00133	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NDUFA13—thyroid cancer	8.85e-05	0.00132	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—TSHR—thyroid cancer	8.6e-05	0.00129	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—PTEN—thyroid cancer	8.54e-05	0.00128	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PRKAR1A—thyroid cancer	8.46e-05	0.00126	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CHST14—thyroid cancer	8.32e-05	0.00124	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—HRAS—thyroid cancer	8.29e-05	0.00124	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NRAS—thyroid cancer	8.09e-05	0.00121	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—HRAS—thyroid cancer	8.08e-05	0.00121	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NRAS—thyroid cancer	7.89e-05	0.00118	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—SST—thyroid cancer	7.36e-05	0.0011	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTCH1—thyroid cancer	7.31e-05	0.00109	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CALCA—thyroid cancer	7.09e-05	0.00106	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—thyroid cancer	6.96e-05	0.00104	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TCF7L1—thyroid cancer	6.94e-05	0.00104	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TPR—thyroid cancer	6.88e-05	0.00103	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—thyroid cancer	6.79e-05	0.00101	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PRKAR1A—thyroid cancer	6.77e-05	0.00101	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HPGD—thyroid cancer	6.71e-05	0.001	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—SST—thyroid cancer	6.69e-05	0.001	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CALCA—thyroid cancer	6.44e-05	0.000962	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—thyroid cancer	6.34e-05	0.000948	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TPR—thyroid cancer	6.32e-05	0.000945	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PRKAR1A—thyroid cancer	6.22e-05	0.000929	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HRAS—thyroid cancer	5.92e-05	0.000885	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—thyroid cancer	5.83e-05	0.000872	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CDK1—thyroid cancer	5.83e-05	0.000871	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—thyroid cancer	5.77e-05	0.000863	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.44e-05	0.000813	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—thyroid cancer	5.23e-05	0.000781	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC5A5—thyroid cancer	5.15e-05	0.00077	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TPR—thyroid cancer	5.1e-05	0.000762	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—thyroid cancer	5.09e-05	0.000762	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TSHR—thyroid cancer	5.08e-05	0.000759	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PRKAR1A—thyroid cancer	5.01e-05	0.00075	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PRKAR1A—thyroid cancer	5e-05	0.000747	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—thyroid cancer	4.86e-05	0.000727	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MEN1—thyroid cancer	4.77e-05	0.000714	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC5A5—thyroid cancer	4.73e-05	0.000707	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—RXRA—thyroid cancer	4.33e-05	0.000647	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTCH1—thyroid cancer	4.32e-05	0.000646	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—RXRA—thyroid cancer	3.97e-05	0.000594	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SST—thyroid cancer	3.95e-05	0.000591	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TPR—thyroid cancer	3.85e-05	0.000576	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC5A5—thyroid cancer	3.82e-05	0.000571	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CALCA—thyroid cancer	3.8e-05	0.000568	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	3.79e-05	0.000567	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDK1—thyroid cancer	3.44e-05	0.000515	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.43e-05	0.000514	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—RXRA—thyroid cancer	3.21e-05	0.000479	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC5A5—thyroid cancer	2.88e-05	0.000431	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRG1—thyroid cancer	2.76e-05	0.000413	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARG—thyroid cancer	2.73e-05	0.000409	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.7e-05	0.000404	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARG—thyroid cancer	2.51e-05	0.000375	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TERT—thyroid cancer	2.48e-05	0.000371	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—RXRA—thyroid cancer	2.42e-05	0.000362	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HIF1A—thyroid cancer	2.37e-05	0.000355	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.36e-05	0.000352	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—thyroid cancer	2.15e-05	0.000321	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NRAS—thyroid cancer	2.09e-05	0.000312	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARG—thyroid cancer	2.02e-05	0.000303	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—thyroid cancer	1.97e-05	0.000295	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.96e-05	0.000294	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTEN—thyroid cancer	1.87e-05	0.00028	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.8e-05	0.000269	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTEN—thyroid cancer	1.72e-05	0.000257	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—thyroid cancer	1.59e-05	0.000238	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARG—thyroid cancer	1.53e-05	0.000229	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—thyroid cancer	1.53e-05	0.000229	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	1.49e-05	0.000222	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—thyroid cancer	1.43e-05	0.000214	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTEN—thyroid cancer	1.39e-05	0.000208	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTEN—thyroid cancer	1.38e-05	0.000207	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—thyroid cancer	1.35e-05	0.000202	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRAS—thyroid cancer	1.23e-05	0.000185	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—thyroid cancer	1.2e-05	0.00018	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—thyroid cancer	1.08e-05	0.000162	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—thyroid cancer	1.06e-05	0.000159	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTEN—thyroid cancer	1.05e-05	0.000157	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—thyroid cancer	9.92e-06	0.000148	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—thyroid cancer	9.44e-06	0.000141	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—thyroid cancer	9.03e-06	0.000135	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—thyroid cancer	8e-06	0.00012	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—thyroid cancer	7.97e-06	0.000119	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—thyroid cancer	6.05e-06	9.04e-05	CbGpPWpGaD
